Department of Psychobiology, Universidade Federal de São Paulo, Brazil.
Sleep Med. 2010 Jun;11(6):545-51. doi: 10.1016/j.sleep.2010.02.010. Epub 2010 May 15.
To evaluate the magnitude of effects of sildenafil on respiratory parameters and heart rate variability (HRV) in slow wave sleep (SWS) and REM sleep of patients with severe obstructive sleep apnea (OSA).
Thirteen male patients with untreated severe OSA (aged 43+/-10 years, body mass index of 26.7+/-1.9 kg/m(2)) were studied on two nights, one with sildenafil 50mg and one with a placebo, in a double-blind, randomized fashion. All-night polysomnography and HRV were simultaneously recorded. Short-term HRV measures were performed in apnea-free intervals. Respiratory parameters were separately assessed in non-REM and REM sleep and compared to total sleep time (TST). Short-term HRV analysis was conducted in samples with regular respiration obtained in SWS and REM sleep.
Comparing to placebo, during sildenafil night there was an increase in apnea-hypopnea index (AHI) in TST and also in non-REM and REM sleep. Increase in central AHI occurred in non-REM sleep; increase in obstructive AHI and decrease in oxyhemoglobin saturation occurred in both non-REM and REM sleep. Additionally, an increase in arousal index and in low/high frequency component of HRV ratio (LF/HF) was significant only in REM sleep. Correlation between sleep architecture and respiratory parameters were more frequent in non-REM sleep for placebo and in REM sleep for sildenafil.
In severe OSA, the use of sildenafil 50mg at bedtime plays a detrimental role on respiratory parameters in both non-REM and REM sleep, fragmentation in REM sleep, and a prolonged increase in LH/HF component of HRV after resumption of ventilation.
评估西地那非对未经治疗的重度阻塞性睡眠呼吸暂停(OSA)患者慢波睡眠(SWS)和快速眼动(REM)睡眠中呼吸参数和心率变异性(HRV)的影响程度。
13 名未接受治疗的重度 OSA 男性患者(年龄 43+/-10 岁,体重指数 26.7+/-1.9 kg/m²)在两个晚上接受了双盲、随机的治疗,一晚给予西地那非 50mg,一晚给予安慰剂。整夜多导睡眠图和 HRV 同时记录。在无呼吸暂停的间隔内进行短期 HRV 测量。呼吸参数分别在非 REM 和 REM 睡眠中进行评估,并与总睡眠时间(TST)进行比较。在 SWS 和 REM 睡眠中获得的规则呼吸样本中进行短期 HRV 分析。
与安慰剂相比,西地那非夜间 TST 及非 REM 和 REM 睡眠中的呼吸暂停低通气指数(AHI)均增加。非 REM 睡眠中的中枢性 AHI 增加;非 REM 和 REM 睡眠中的阻塞性 AHI 增加和氧合血红蛋白饱和度降低。此外,仅在 REM 睡眠中,觉醒指数和 HRV 低频/高频成分比值(LF/HF)的增加具有统计学意义。对于安慰剂,睡眠结构与呼吸参数之间的相关性在非 REM 睡眠中更为频繁;对于西地那非,这种相关性在 REM 睡眠中更为频繁。
在重度 OSA 患者中,睡前使用 50mg 西地那非可导致非 REM 和 REM 睡眠中的呼吸参数恶化、REM 睡眠中的睡眠片段化增加以及通气恢复后 LF/HF 成分的 HRV 延长。